Ditchcarbon
  • Contact
  1. Organizations
  2. LungLife AI, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 6 days ago

LungLife AI, Inc. Sustainability Profile

Company website

LungLife AI, Inc., headquartered in the United States, is a pioneering company in the healthcare technology sector, specialising in advanced diagnostic solutions for lung cancer. Founded in 2018, LungLife AI has made significant strides in leveraging artificial intelligence to enhance the accuracy and efficiency of lung cancer detection, positioning itself as a leader in the oncology diagnostics market. The company’s flagship product, the LungLife AI platform, utilises cutting-edge machine learning algorithms to analyse patient data, providing clinicians with actionable insights that improve patient outcomes. This innovative approach not only streamlines the diagnostic process but also sets LungLife AI apart from traditional methods. With a commitment to transforming lung cancer care, LungLife AI continues to achieve notable milestones, solidifying its reputation as a key player in the fight against this prevalent disease.

DitchCarbon Score

How does LungLife AI, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

LungLife AI, Inc.'s score of 27 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

LungLife AI, Inc.'s reported carbon emissions

In 2022, LungLife AI, Inc. reported total carbon emissions of approximately 1,347,800 kg CO2e, comprising 404,000 kg CO2e from Scope 1, 282,600 kg CO2e from Scope 2, and 661,200 kg CO2e from Scope 3 emissions. This data reflects a significant operational footprint, with the majority of emissions stemming from Scope 3, which typically includes indirect emissions from the supply chain and product use. In 2021, the company reported a much higher Scope 1 emission total of approximately 533,000,000 kg CO2e, indicating a substantial reduction in direct emissions in the following year. However, no specific reduction targets or climate pledges have been documented, and there are no cascading emissions data from a parent or related organization. LungLife AI, Inc. is committed to addressing its carbon footprint, although specific initiatives or targets have not been outlined. The absence of formal reduction commitments suggests an opportunity for the company to enhance its climate strategy in alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20212022
Scope 1
533,000,000
000,000
Scope 2
-
000,000
Scope 3
-
000,000

How Carbon Intensive is LungLife AI, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. LungLife AI, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is LungLife AI, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for LungLife AI, Inc. is in US, which has a low grid carbon intensity relative to other regions.

LungLife AI, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

LungLife AI, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare LungLife AI, Inc.'s Emissions with Industry Peers

NantHealth, Inc.

US
•
Computer and related services (72)
Updated 7 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Freenome Holdings, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Foundation Medicine, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Guardant Health

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

ANGLE plc

GB
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251125.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy